Peter Mitchell, the man who discovered the chemiosmotic energy transduction mechanism. 

Peter Mitchell, the man who discovered the chemiosmotic energy transduction mechanism. 

Contexts in source publication

Context 1
... Keilin's discovery, Peter Mitchell ( Fig. 5) pro- posed the chemiosmotic theory to explain the mecha- nism used by mitochondria to synthesize ATP (15). Ac- cording to this theory, the energy derived from the flux of electrons through the cytochrome chain is used to ex- clude protons from the inner membrane into the space available between the two mitochondrial membranes, thus generating a proton gradient across the inner mito- chondrial membrane and the matrix (electric and os- motic energies). The H gradient is then dissipated through the mitochondrial F 1 F 0 -ATP synthase, a com- plex enzyme that has several subunits, with some em- bedded into the inner membrane and others protruding from the inner mitochondrial membrane and facing the matrix. During the H efflux through the F 1 F 0 complex, the energy derived from the gradient is converted into chemical energy to synthesize ATP from ADP and P i ...
Context 2
... medium but in a theoretical condition in which the solvent would not bind to the reactants. The values found were quite different from those measured in water, thus supporting the proposal of George et al. (39). Accord- ing to these calculations, the energy of hydrolysis of an acyl phosphate residue solvated in water would be in the range of 8 to 10 kcal/mol but increased to 5 to 32.5 kcal/ mol in the gas phase. We then reasoned that the interac- tion of water with the reactant should decrease if we decreased the water activity of the solvent, thus mimicking the gas phase. We then raised the possibility that in the E 2 conformation, the catalytic site of the enzyme would be hydrophobic and that the solvation of both P i and the aspartate residue would decrease to a point that phos- phorylation would occur spontaneously (E 2 -P). In this case, the major thermodynamic barrier for the formation of the acyl phosphate residue would be not the formation of the covalent bond (Fig. 9A, reaction 5) but the binding of P i to the enzyme, i.e. the partitioning of a hydrophilic ion (P i ) from the aqueous assay medium into the hydrophobic environment of the catalytic site. Factors facilitating this partition should also facilitate the phosphorylation of the enzyme by P i . The phosphoenzyme E 2 -P formed from P i would not be able to transfer its phosphate to ADP because of the large difference in the energies of hydrolysis of the acyl phosphate in a hydrophobic environment and ATP in an aqueous solution. The binding of Ca 2 to the low-affinity site of the enzyme would then promote a con- formational change in the protein that would allow the entry of water into the catalytic site with the subsequent solvation of both the acyl phosphate residue and ADP. As a result, the energy values for the hydrolysis of the acyl phosphate and ATP would become equally high, and ATP synthesis would proceed spontaneously. Experimental conditions that reduce the entry of water into the catalytic site should also impede the synthesis of ATP. According to this hypothesis, the existence of high-and low-energy forms of the phosphoenzyme would be related solely to the water activity in the catalytic site. We tested this hypothesis by measuring the phosphorylation of the enzyme by P i and the synthesis of ATP in the presence of water and various concentrations of nondenaturing organic solvents such as dimethyl sulfoxide, glycerol, and N,N-dimethylformamide (34,(41)(42)(43). In aqueous mix- tures, these solvents markedly increase the partition coef- ficient of P i from the aqueous medium into an organic phase containing isobutyl alcohol and benzene. In previ- ous studies, we observed that in the absence of a gradient, the phosphorylation of E 2 by P i demonstrated a saturation behavior (24, 25, 31, 35), indicating the occurrence of a phosphate-enzyme complex prior to the phosphorylation reaction (Reaction ...
Context 3
... had the good fortune to be invited by Peter Mitchell (Fig. 5) for a three-day sojourn to his laboratory at the Glynn Research Centre near Bodmin, Cornwall, United Kingdom. This was an exciting adventure. When I took the train from London, I was expecting to find a tall building crowded with all sorts of laboratories. Instead, the train stopped in a small station in the countryside. The crowded building I had imagined was in fact a lovely mansion located on a farm with a small lake, cows, ducks, and everything else required for a peaceful and in- spiring environment. The research team was restricted to a staff of three: his colleague, Jennifer Moyle; a secre- tary; and another woman who took care of a rich library. At that time, there was no internet, and we had to go to printed journals to collect information. Peter was waiting for me at the entrance of the mansion and took me di- rectly to his laboratory. The first thing he showed me was a world map full of pins. Red pins located research groups that criticized his theory, white were neutral, and green supported the chemiosmotic theory. I had three lovely days of friendly discussion. On the train back to London, I could not remember clearly what specific top- ics we had discussed, but I knew that my way of thinking about energy interconversion had changed for the ...

Similar publications

Article
Full-text available
Biographical notes describe the life and scientific activities of Yuri Balashov, an outstanding Russian parasitologist, the Chief Editor of Parazitologiya.

Citations

... Intracellular phosphate is part of information storage (DNA and RNA), signaling pathways, plays a role in the activation of enzymes/proteins through phosphorylation and cyclic adenosine monophosphate (cAMP), and during energy metabolism and the generation of adenosine triphosphate (ATP). This latter consists of two highly reactive bonds that represent a fundamental source of energy to carry out the mechanical, chemical, electrical, thermal, and osmotic work necessary for every living organism [7,8]. In the presence of phosphatase, ATP can transfer onto molecules of other compounds a particular group of its molecule together with a part of the energy associated with it [8]. ...
Article
Full-text available
Neridronate or ((6-amino-1-hydroxy-1-phosphonohexyl) phosphonic acid) is an amino-bisphosphonate (BP) synthetized in Italy in 1986. Bisphosphonates are molecules with a P-C-P bond in their structure that allows strong and selectively binding to hydroxyapatite (HAP) as well as osteoclasts inhibition through different mechanisms of action. Neridronate was initially used to treat Paget disease of the bone, demonstrating effectiveness in reducing bone turnover markers as well as pain. The interesting molecular properties of neridronate foster its wide use in several other conditions, such as osteogenesis imperfecta, and osteoporosis. Thanks to the unique safety and efficacy profile, neridronate has been used in secondary osteoporosis due to genetic, rheumatic, and oncological diseases, including in pediatric patients. In the last decade, this drug has also been studied in chronic musculoskeletal pain conditions, such as algodystrophy, demonstrating effectiveness in improving extraskeletal outcomes. This review highlights historical and clinical insights about the use of neridronate for metabolic bone disorders and musculoskeletal pain conditions.
... Low-energy phosphates are usually linked to phosphoester bonds, which will release 2 and 3 kcal/mol energy. HEPs include a variety of phosphate compounds with energies of hydrolysis higher than 7 kcal/mol (24). ATP and CrP are considered to be the primary HEPs in human body. ...
Article
Full-text available
The purpose of this review is to bridge the gap between clinical and basic research through providing a comprehensive and concise description of the cellular and molecular aspects of cardioprotective mechanisms and a critical evaluation of the clinical evidence of high-energy phosphates (HEPs) in ischemic heart disease (IHD). According to the well-documented physiological, pathophysiological and pharmacological properties of HEPs, exogenous creatine phosphate (CrP) may be considered as an ideal metabolic regulator. It plays cardioprotection roles from upstream to downstream of myocardial ischemia through multiple complex mechanisms, including but not limited to replenishment of cellular energy. Although exogenous CrP administration has not been shown to improve long-term survival, the beneficial effects on multiple secondary but important outcomes and short-term survival are concordant with its pathophysiological and pharmacological effects. There is urgent need for high-quality multicentre RCTs to confirm long-term survival improvement in the future.
... Cellular respiration is vital for life and is a highly exergonic process in which redox reactions evolved to conserve part of the free energy transiently in molecules of phosphoanhydride and phosphoester bonds, such as ATP, PPi, phosphocreatine, and glucose-6-phosphate (G6P) (de Meis 1997(de Meis , 2012; and also in carrier coenzymes of electrons and protons (2e -+ 2H + → H 2(g) ) such as NAD(P)H, FADH 2 , or any other general H 2(g) acceptors from nutrients avoiding H 2(g) escape from biological systems to environmental atmosphere. Electrons and protons are ultimately attracted to molecular oxygen (O 2 ) by its great thermodynamic electron affinity expressed in a high standard reduction potential value (E°′ = +816 mV) forming H 2 O (Skulachev et al. 2013). ...
Chapter
Although heart diseases continue to be the leading cause of death worldwide, advances performed in recent decades have facilitated a decrease in the mortality rate related to severe heart diseases. This is due to the recognition that has been acquiring the role of the immune system and its contribution to the progression of heart disease. Recent studies have shown that there is a close relationship between cardiac disturbances and inflammatory mediators produced by immune system cells since there is a close interaction between the innate and adaptive immune response in the pathophysiology of heart diseases. Regarding innate immune response, macrophages are the leading cells, which play a fundamental role in a wide variety of cardiac disorders. These cells produce a variety of cytokines that open up a wide range of therapeutic possibilities in the treatment of heart diseases. However, under certain circumstances, it is known that immune system cells can cause irreparable damage that contributes to heart failure. Therefore, it is essential to study the crosstalk between innate and adaptive response in order to better understand the mechanism of action of the different cardiac disturbances. In this sense, biotechnology emerges as a pioneering tool that allows on the one hand to effectively detect the various cardiovascular and inflammatory diseases, and on the other, to develop innovative therapies that result in effective treatments.
Chapter
The brain is a crucial organ that integrates very rapidly several complex sensory functions contributing to the fitness of different mammal species to capture energy from its environment. To achieve this evolutionary success a high flow per specific brain mass of oxygen and glucose was adapted for obtaining ATP by oxidative phosphorylation. However, this high flow of glucose and oxygen inserts the brain at serious risk of oxidative stress, cell death, and inflammation that is present in degeneration process of inflammatory diseases and aging. Interestingly, during the development of the brain, several redox signals generated by reactive oxygen species (ROS) are necessary and are highly controlled in time and space by mitochondria. In central nervous system, the consumption of oxygen and the first reaction of glucose metabolism occurs together and mainly at the mitochondrial surface through the coupling of hexokinase in the outer mitochondrial membrane (OMM). The reasons for this strategic association go beyond the activation of glucose in cellular metabolism, because it involves a strong control of the release of mitochondrial ROS (mROS), mitochondrial uptake, management of calcium, and opening of the permeability transition pore. In this way, downstream redox signals can be indirectly regulated by the mitochondrial glucose phosphorylation by hexokinase and mROS release. The implication of this unique mitochondrial glucose phosphorylation extrapolates the central nervous system, contributing to the anti-aging and inflammation responses in different tissues and defense systems and species of mammals. Thus, hexokinase coupled to mitochondria may works as a glucose-OxPhos-redox transducer system, especially present in long-lived species tolerant to inflammation, viral infection, and pathogens.KeywordsHexokinaseMitochondriaROSRedox signalingInflammationAgingGlucoseOxygen